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1442Background: Patients at high and low body mass index have been shown to experience higher morbidity and
mortality when undergoing coronary artery bypass grafting. The purpose of this research was to compare out-
comes of patients at body mass index extremes who underwent coronary artery bypass grafting with or without
cardiopulmonary bypass.
Methods: A retrospective review of 6801 patients with a body mass index<25 or>35 undergoing isolated, pri-
mary coronary artery bypass grafting from 1996 to 2009 at Emory Healthcare Hospitals was performed. Patients
were compared by therapy either on-pump coronary artery bypass grafting (n ¼ 3210) or off-pump coronary
artery bypass grafting (n ¼ 3591). Salvage patients or those with concomitant operations were excluded. Com-
parisons were made using multivariable regression analysis, using a propensity score covariate calculated from
41 preoperative risk factors.
Results:A total of 6801 patients, including 4312 with a body mass index<25 (off-pump coronary artery bypass
grafting, n ¼ 2083; on-pump coronary artery bypass grafting, n ¼ 2229) and 2489 with a body mass index>35
(off-pump coronary artery bypass grafting, n¼ 1127; on-pump coronary artery bypass grafting, n¼ 1362) were
included for analysis. Society of Thoracic Surgeons predicted risk of mortality was significantly higher for both
bodymass index strata in patients undergoing off-pump coronary artery bypass grafting (2.8% vs 3.1% for body
mass index<25 [P ¼ .043] and 1.7% vs 1.8% for body mass index>35 [P ¼ .049]). For patients with a body
mass index<25, multivariable analysis of outcomes showed a significant decrease in in-hospital mortality
(adjusted odds ratio, 0.48; 95% confidence interval, 0.28-0.82), stroke (adjusted odds ratio, 0.31; 95% confi-
dence interval, 0.18-0.56), new-onset renal failure (adjusted odds ratio, 0.59; 95% confidence interval,
0.36-0.96), and prolonged ventilation (adjusted odds ratio, 0.50; 95% confidence interval, 0.38-0.64). Long-
term survival was unaffected by method of revascularization for either body mass index strata (P>.05).
Conclusions: Patients with high and low body mass indices experience reduced morbidity and in-hospital mor-
tality when undergoing off-pump coronary artery bypass grafting. Despite a higher risk profile, patients with
a body mass index<25 who underwent off-pump coronary artery bypass grafting experienced a significant
reduction in in-hospital mortality. (J Thorac Cardiovasc Surg 2013;146:1442-8)Surgical coronary revascularization has been established as
an effective method of providing a lasting source of nutrient
blood flow to areas of ischemic myocardium.1-5 Long-term
results of coronary artery bypass grafting (CABG) reflect
growing expertise with a variety of techniques and con-
duit choices.2,4-7 Excellent survival among a variety of
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The Journal of Thoracic and Cardiovascular Surincluding those with certain anatomic considerations like
left main coronary artery stenosis and 3-vessel disease.8-10
Off-pump coronary artery bypass grafting (OPCAB) is
a technique that aims to provide equivalent coronary revas-
cularization without the assistance of cardiopulmonary by-
pass (CPB). Published results of patients undergoing
OPCAB, however, have been mixed. In a large, randomized
trial published recently that included>2200 patients, 1-year
composite outcomes and graft patency rates were worse in
patients undergoing OPCAB when compared with on-
pump CABG (ONCAB).11 Other trials with more practiced
surgeons, however, have found equivalent rates of mid-term
graft patency and reductions in short- and mid-term mortal-
ity.12-14 Specifically, recent data indicated that patients at
highest risk for mortality from CABG derive the greatest
benefit from OPCAB.15
Low body mass index (BMI) has been investigated previ-
ously as an independent risk factor for morbidity and mor-
tality following CABG. In a mixed cardiac surgical
population of>5000 patients, Engelman and colleagues16gery c December 2013
Abbreviations and Acronyms
AOR ¼ adjusted odds ratio
BMI ¼ body mass index
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
ONCAB¼ on-pump coronary artery bypass grafting
OPCAB ¼ off-pump coronary artery bypass
grafting
PS ¼ propensity scoring
SSDI ¼ Social Security Death Index
STS ¼ Society of Thoracic Surgeons
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Dreported that low BMI as well as low preoperative serum
albumin led to increased morbidity and mortality after
cardiac surgery. More than 30% of these patients, however,
underwent some type of valve surgery, and all procedures
were performed with the aid of CPB. Potapov and associ-
ates17 reported that patients with a BMI< 25 in 23,000
European patients experienced a significant increase in
morbidity, including reintubation and reexploration for
hemorrhage. More than 17,000 isolated CABG procedures
were included for analysis, but OPCAB cases were not
documented.
Because patients at body mass extremes have been
proved to incur increased morbidity and mortality after
CABG, we sought to determine the impact of OPCAB on
outcomes in these high-risk groups. The purpose of this re-
search was to compare short- and long-term outcomes of
ONCAB vs OPCAB for patients with a BMI<25 or>35.
METHODS
Experimental Design
This research sought to compare 2 different methods of coronary revas-
cularization (ONCAB and OPCAB) and the outcomes of patients after the
procedures. Patients were identified by querying the Emory University in-
stitutional Society of Thoracic Surgeons (STS) Adult Cardiac Database for
consecutive patients who underwent isolated CABG at Emory Healthcare
Hospitals between January 1, 1996, and December 31, 2009. Patients un-
dergoing another concomitant cardiac procedure and salvage operations
were excluded. Redo CABG patients, however, were included in this
analysis.
During the study period, 19,935 patients underwent CABG and 6801
(34.1%) met inclusion criteria and were included for analysis. A variable
for conversion from OPCAB to ONCAB was collected starting only in
2002 and was unavailable for much of the study period; thus, patients
were classified according to the treatment they ultimately received. Body
mass index was calculated by dividing the patient’s weight in kilograms
by the square of the patient’s height in meters. Each patient was classified
as either<25 BMI or>35 BMI. Patients in the range from 25 to 35 BMI
were excluded from the study. Extracted patient records included demo-
graphic data, preexisting comorbidities, and clinical outcomes. The study
was approved by the Emory University institutional review board in com-
pliance with Health Insurance Portability and Accountability Act regula-
tions and the Declaration of Helsinki. The institutional review board
waived individual patient consent secondary to the retrospective nature
of the study.The Journal of Thoracic and CarProcedural Information
During the study period, 20 surgeons performed the procedures in-
cluded in this analysis. Decisions regarding operative therapy (ONCAB
vs OPCAB) were made exclusively by the attending surgeon. For patients
undergoing ONCAB procedures, standard CPB procedures were followed.
Cold antegrade and/or retrograde cardioplegia was used routinely at the
discretion of the attending surgeon. Typically, conventional CPB per-
formed using roller head pumps, membrane oxygenators, cardiotomy suc-
tion, arterial filters, and moderate systemic hypothermia (34C). Off-pump
CABG procedures were performed under normothermic conditions with
the heart beating continuously. Cardiac positioning was facilitated by the
use of commercially available stabilizers and positioning devices. For pa-
tients undergoing both ONCAB and OPCAB procedures, routine utiliza-
tion of epi-aortic ultrasound scanning of the ascending aorta was used to
assess for atheromatous disease prior to cannulation and/or the construction
of proximal anastomoses. In general, proximal anastomoses for patients
undergoing ONCAB were performed under a single crossclamp, and prox-
imal anastomoses for patients who underwent OPCAB were performed
with the aid of a partial occlusion clamp, although these methods varied
by surgeon and patient.
Outcomes and Long-Term Follow-up
Postoperative clinical outcomes of interest included in-hospital mortal-
ity, permanent stroke, myocardial infarction, major adverse cardiac events
(composite of death, permanent stroke or myocardial infarction), mediasti-
nitis (deep sternal wound infection within 30 days), septicemia, worsening
renal failure, new dialysis, and prolonged ventilation. Also, the Social
Security Death Index (SSDI) is a publicly available national database of
death records extracted from the U.S. Social Security Administration’s
Death Master File Extract. Patients with a Social Security number who
have died since 1963 and whose death has been reported to the Social
Security Administration are listed in the SSDI. For each patient that
died prior to the cutoff date of March 30, 2009, a mortality date was pro-
vided, allowing Kaplan-Meier long-term survival curves to be generated.
Cause of death is not available; thus, this study describes all-cause
long-term mortality.
Statistical Analysis
Propensity scoring (PS) analysis was used to mediate selection bias.
Propensity analysis involves calculating the probability of being assigned
to the treated group and using this probability to make inferences about
group effects. In this study, patients were assigned to either OPCAB or
standard ONCAB using 41 covariates collected preoperatively, including
surgeon identity. Notably, some of these variables have more than 2 levels
(such as surgeon, for example) and represent more degrees of freedom in
the propensity estimation model than dichotomous or numeric variables.
After this PS was calculated for each study patient, it was used as a regres-
sion covariate when comparing surgery type. More important, BMI was
omitted in calculating the PS because independent inferences were also
made for this variable.
To evaluate statistically the effects of surgery type on clinical outcomes
in the BMI subgroups, multivariable logistic regression models were con-
structed. The primary variable under consideration was surgery type
(ONCAB or OPCAB). Each model for each outcome was adjusted with
the propensity score to account for preoperative differences in the groups.
The relationship between OPCAB and ONCAB was examined separately
within the BMI strata, and examined for differences across strata (indica-
tive of an interaction). Adjusted odds ratios (AORs), along with 95% con-
fidence intervals, were computed for each predictor. The reference group
for surgery type was OPCAB.
Kaplan-Meier curves were generated that provide unadjusted long-term
survival estimates for each BMI group stratified by surgery type. Differ-
ences between strata were determined by log-rank tests. Also, 1-, 3-, 5-,
10-, and 12-year survival was estimated for each combination of BMIdiovascular Surgery c Volume 146, Number 6 1443
TABLE 1. Preoperative demographics
Characteristic
BMI  25 BMI  35
ONCAB (n ¼ 2083) OPCAB (n ¼ 2229) P value ONCAB (n ¼ 1127) OPCAB (n ¼ 1362) P value
Age, mean  SD 65.7  1 0.9 66.6  11.6 .006 58.2  10.1 58.9  10.5 .08
Female gender, n (%) 653 (31.4) 796 (35.7) <.001 408 (36.2) 573 (42.1) .003
White, n (%) 1680 (83.1) 1712 (77.4) <.001 891 (80.9) 1004 (74.1) <.001
Status, n (%)
Elective 1673 (80.3) 1512 (67.8) <.001 897 (79.6) 929 (68.2) <.001
Urgent 236 (11.3) 645 (28.9) 154 (13.7) 394 (28.9)
Emergency 174 (8.4) 72 (3.2) 76 (6.7) 39 (2.9)
Ejection fraction,%; mean  SD 48.4  13.7 50.3  13.1 <.001 49.9  12.5 51.8  11.9 <.001
Hypertension, n (%) 1405 (67.5) 1738 (78.0) <.001 949 (84.2) 1216 (89.3) <.001
Chronic lung disease, n (%) 389 (18.7) 489 (21.9) .008 141 (12.5) 241 (17.7) <.001
Previous myocardial infarction, n (%) 1166 (56.0) 1178 (52.9) .039 620 (55.0) 693 (50.9) .04
Previous CVA, n (%) 182 (8.7) 252 (11.3) .005 76 (6.7) 119 (8.7) .07
Previous valve surgery, n (%) 7 (0.3) 5 (0.2) .49 2 (0.2) 2 (0.2) .85
Previous sternotomy, n (%) 167 (8.0) 65 (2.9) <.001 81 (7.2) 32 (2.3) <.001
BMI, mean  SD 22.8  1.9 22.5  2.0 <.001 39.2  4.2 39.6  4.6 .012
Cerebrovascular disease, n (%) 330 (15.8) 470 (21.1) <.001 114 (10.1) 192 (14.1) .003
Peripheral vascular disease, n (%) 196 (9.4) 378 (17.0) <.001 72 (6.4) 123 (9.0) .015
Serum creatinine, mean  SD 1.24  1.07 1.28  1.30 .41 1.19  0.88 1.27  1.30 .08
Chronic renal insufficiency, n (%) 155 (7.4) 170 (7.6) .82 77 (6.8) 98 (7.2) .72
Preoperative dialysis, n (%) 39 (1.9) 82 (3.7) <.001 11 (1.0) 36 (2.6) .002
Dyslipidemia, n (%) 450 (21.6) 1379 (61.9) <.001 334 (29.6) 926 (68.0) <.001
Current smoker, n (%) 786 (37.7) 1256 (56.4) <.001 393 (34.9) 637 (46.8) <.001
Preoperative IABP, n (%) 75 (3.6) 57 (2.6) .047 40 (3.6) 35 (2.6) .15
Immunosuppressive therapy, n (%) 50 (2.4) 101 (4.5) <.001 26 (2.3) 44 (3.2) .17
STS PROM, mean  SD 0.028  0.035 0.031  0.043 .043 0.017  0.021 0.018  0.025 .049
BMI, Body mass index; ONCAB, on-pump coronary artery bypass grafting; OPCAB, off-pump coronary artery bypass grafting; SD, standard deviation; CVA, cerebrovascular
accident; IABP, intra-aortic balloon pump; STS PROM, Society of Thoracic Surgeons predicted risk of mortality.
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vest dates were excluded from the survival analysis.
Last, kernel estimation with uniform smoothing was used to assess vi-
sually the relationship between numeric BMI and mortality rates. A plot
was created in which the x-axis was BMI and the y-axis was observed mor-
tality. Because observed mortality is dichotomous, the points on the plot at
each BMI value are calculated by taking an average of the observed mor-
tality (so-called uniform kernel smoothing) for a neighborhood around the
BMI value. The neighborhood is defined as the collection of points within
a small range around the BMI value; thus, the point on the plot is the aver-
age mortality rate for that neighborhood of BMI values. The width of each
neighborhood was held fixed at 10%.
The data were managed and analyzed using SAS version 9.2 (SAS In-
stitute, Inc, Cary, NC). Unadjusted comparisons were performed with c2
tests and 2-sample t tests for categoric and numeric predictors, respectively.
All statistical tests were 2-sided using an a ¼ .05 level of significance.
No multiple comparisons adjustments were deemed necessary.RESULTS
Preoperative and Operative Data
Of the 6801 patients included for analysis, 4312 patients
had a BMI<25 and 2489 had a BMI>35. Preoperative de-
mographics are highlighted in Table 1. Most notable, pa-
tients who underwent OPCAB in both BMI groups were
older, more frequently female, less frequently white, and
had a greater incidence of many preoperative comorbidities.
Patients undergoing ONCAB had a significantly lower1444 The Journal of Thoracic and Cardiovascular Surejection fraction and higher incidence of redo surgery
than their OPCAB counterparts, but STS predicted risk of
mortality was significantly greater for the OPCAB groups
in both BMI strata.
Operative data including CPB and ischemic times are de-
tailed in Table 2. There was a higher incidence of redo sur-
gery in those patients who underwent ONCAB, and
intraoperative intra-aortic balloon counterpulsation was
more frequent in ONCAB patients.Postoperative Outcomes
Adjusted outcomes using a multivariable propensity
analysis of preoperative covariates are detailed in Table
3. Most notable are the outcomes for the group of patients
with a BMI< 25. There was a significantly decreased in-
cidence of death (AOR ¼ 0.48), stroke (AOR ¼ 0.31), ma-
jor adverse cardiac events (AOR ¼ 0.41), mediastinitis
(AOR ¼ 0.13), new-onset renal failure (AOR ¼ 0.59),
and prolonged ventilation (AOR ¼ 0.50) associated with
the OPCAB group. For patients with a BMI> 35, only
major adverse cardiac events were reduced significantly
with OPCAB (AOR ¼ 0.51). Figure 1 depicts in-hospital
mortality by BMI and surgery type using a smooth kernel
estimation. On-pump CABG patients with BMI < 25gery c December 2013
TABLE 2. Operative data by body mass index classification and surgery type
Operative variable
BMI  25
ONCAB (n ¼ 2083)
BMI  25
OPCAB (n ¼ 2229)
P
value
BMI  35
ONCAB (n ¼ 1127)
BMI  35
OPCAB (n ¼ 1362)
P
value
Aortic crossclamp time, min; mean  SD 49.5  23.7 0 — 53.2  24.2 0 —
CPB time, min; mean  SD 92.5  30.0 0 — 96.5  31.8 0 —
No. of distal Anastomosis, mean  SD 3.45  0.97 2.91  1.07 <.001 3.51  0.94 2.93  1.08 <.001
No. of proximal anastomosis, mean  SD 1.58  1.25 1.40  1.05 <.001 1.52  1.27 1.33  1.04 <.001
LITA usage, n (%) 1771 (85.0) 1897 (85.1) .94 999 (88.6) 1212 (89.0) .79
Intraoperative IABP insertion, n (%) 104 (5.0) 39 (1.8) <.001 40 (3.6) 14 (1.0) <.001
BMI, Body mass index; ONCAB, on-pump coronary artery bypass grafting; OPCAB, off-pump coronary artery bypass grafting; SD, standard deviation; CPB, cardiopulmonary
bypass; LITA, left internal thoracic artery; IABP, intra-aortic balloon pump.
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counterparts.
Long-Term Outcomes
Long-term survival is detailed in Table 4 and Figures 1
and 2. The most notable divide is between underweight
and overweight patients. Underweight patients have poorer
early survival, and the survival gap continues to widen out
to 12 years. Although there was an improvement in short-
term mortality, long-term mortality is not different between
surgery type in either underweight or overweight patients.
However, there is a statistically improved survival in all
patients with a BMI > 35 compared with those with
a BMI<25 (P<.001).
DISCUSSION
Surgical coronary revascularization has long been estab-
lished as an important and effective component for treat-
ment for certain patients with coronary artery disease.
Most recent research involving CABG has sought to evalu-
ate modifiable variables surrounding operative conduct and
patient selection to improve short- and long-term outcomes.
On-pump CABG represented one such innovation: the
possibility of avoiding CPB while providing equivalent re-
vascularization may benefit certain patient populations. Not
surprisingly, OPCAB has been shown to benefit thoseTABLE 3. Multivariable adjusted analysis of postoperative outcomes
OUTCOME
BMI<25
ONCAB (n ¼ 2083) OPCAB (n ¼ 2229) AOR (9
Death 78 (3.7) 36 (1.6) 0.48 (0.2
Stroke 65 (3.1) 28 (1.3) 0.31 (0.1
Myocardial infarction 26 (1.3) 16 (0.7) 0.62 (0.2
Major adverse cardiac
events
154 (7.4) 73 (3.3) 0.41 (0.2
Mediastinitis 19 (0.9) 6 (0.3) 0.13 (0.0
Septicemia 35 (1.7) 28 (1.3) 1.04 (0.5
Renal failure 72 (3.5) 52 (2.3) 0.59 (0.3
New dialysis 18 (0.9) 18 (0.8) 0.45 (0.1
Prolonged ventilation 230 (12.8) 230 (10.7) 0.50 (0.3
BMI, Body mass index;ONCAB, on-pump coronary artery bypass grafting;OPCAB, off-pu
*P<.05.
The Journal of Thoracic and Carpatients at highest preoperative risk.15 What has yet to be
detailed completely is the risk that low BMI poses to
patients in terms of short- and long-term outcomes. Of the
3 commonly used preoperative risk calculators used in car-
diac surgery, only the STS risk assessment calculator has in-
puts available to account for individual body mass
indices.18-20
This study reinforces results published by prior re-
searchers, specifically that patients with a low BMI incurred
greater morbidity and mortality after CABG.16,17 The
novelty of this study, however, was the comparison
between patients at body mass extremes undergoing
OPCAB versus ONCAB. The decision to label BMI
parameters extreme at>35 and<25 stemmed from data
from our own institution as well as prior research
conducted on the subjects of cardiac surgery and
BMI.16,17,21 On univariate analysis of the 4 groups of
patients, the 2 OPCAB groups had notably more
preoperative comorbidities than the 2 ONCAB groups,
including higher preoperative rates of cerebrovascular
disease and chronic lung disease. There were exceptions;
both ONCAB groups had statistically lower ejection
fractions than their respective OPCAB counterparts.
When STS predicted risk of mortality scores were
compared, both OPCAB groups had significantly higher
predicted risk of mortality scores than ONCAB groups.BMI>35
5% CI) ONCAB (n ¼ 1127) OPCAB (n ¼ 1362) AOR (95% CI)
8-0.82)* 24 (2.1) 15 (1.1) 0.45 (0.19-1.07)
8-0.56)* 16 (1.4) 19 (1.4) 0.52 (0.22-1.23)
6-1.49) 12 (1.1) 5 (0.4) 1.18 (0.26-5.28)
8-0.60)* 49 (4.4) 36 (2.6) 0.51 (0.28-0.93)*
5-0.38)* 33 (2.9) 27 (2.0) 0.59 (0.29-1.19)
0-2.15) 20 (1.8) 21 (1.5) 0.70 (0.30-1.62)
6-0.96)* 66 (5.9) 84 (6.2) 0.81 (0.52-1.29)
9-1.05) 15 (1.3) 25 (1.8) 0.74 (0.32-1.72)
8-0.64)* 136 (13.5) 223 (16.7) 0.77 (0.57-1.05)
mp coronary artery bypass grafting; AOR, adjusted odds ratio; CI, confidence interval.
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FIGURE 1. Smooth kernel estimation of mortality by body mass index for off-pump coronary artery bypass grafting and on-pump coronary artery bypass
grafting. OPCAB, Off-pump coronary artery bypass grafting; BMI, body mass index; ONCAB, on-pump coronary artery bypass grafting.
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mic and CPB times for the ONCAB groups. Not surprising,
both ONCAB groups had a greater number of distal targets
grafted. This follows with previously published data from
our institution detailing a greater proportion of ONCAB
procedures for patients with a greater number of distal tar-
gets without sacrificing completeness of revasculariza-
tion.22,23 The incidence of intraoperative intra-aortic
balloon pump insertion was higher in both ONCAB groups.
This fact may be best explained by the increased incidence
of emergency operations performed in the ONCAB
populations.
Postoperative adverse events were decreased for both
groups undergoing OPCAB, but the differences were
more notable for patients at low BMI. Patients with
a BMI<25 undergoing OPCAB experienced significantly
lower rates of postoperative mortality, stroke, and new-
onset renal failure. Composite outcomes (stroke, death,
myocardial infarction) were improved for patients undergo-
ing OPCAB in both BMI groups. Reasons for the improved
outcomes observed include the potential for decreased
transfusion requirements following OPCAB, a decreased
inflammatory response associated with CPB avoidance,
and an increased intraoperative intra-aortic balloon pump
counterpulsation requirement for patients who underwent
ONCAB. A decreased inflammatory response when com-
pared with ONCAB has been noted in prior works detailing
OPCAB, but this data set does not include serologic data re-
garding inflammatory markers.24,25 Patients with a lowBMITABLE 4. Long-term outcomes by body mass index and procedure
Patient group 1-y survival,% 3-y survival,% 5-y su
BMI<25 OPCAB 92.9 85.0
BMI<25 ONCAB 91.2 85.1
BMI>35 OPCAB 95.7 90.4
BMI>35 ONCAB 95.4 92.3
OPCAB 93.9 87.0
ONCAB 92.6 87.6
Underweight 92.0 85.2
Overweight 95.6 91.4
BMI, Body mass index; OPCAB, off-pump coronary artery bypass grafting; ONCAB, on-p
1446 The Journal of Thoracic and Cardiovascular Surmay derive benefit preferentially from avoidance of CPB
and decreased levels of postoperative circulating levels of
proinflammatory cytokines.
Long-termoutcomes for patientswith a lowBMIwere un-
affected by the type of surgical revascularization. Survival
rates at every postoperative time point were lower for pa-
tients with a BMI<25 when compared with patients with
a BMI>35. Although no direct comparisons were made be-
tween BMI groups, it stood to reason that patients with
a lower BMI may be less fit than their obese counterparts
at the time of surgery. In addition, the convergence in
long-term mortality could be explained potentially by the
decrease in completeness of revascularization in OPCAB
patients or by a similar progression of disease that rendered
revascularization methods equal over prolonged periods.
The STS predicted risk of mortality was higher for patients
with BMI<25 regardless of surgical intervention, and post-
operative observed mortality was higher as well.
Limitations
This was a retrospective observational study and was
subject to the usual limitations of this sort of study—most
notable, the inability to have full investigative control
over the primary study factors. In addition, individual sur-
geon decision making and technique could not be accounted
for in a study of this magnitude. Although practices have
been largely standardized, interoperator variability still
existed. Also, patients were analyzed according to the treat-
ment they ultimately received. There were 195 conversionsrvival,% 10-y survival,% 12-y survival,% P value
76.2 57.8 51.3 .52
78.1 57.4 48.9
85.3 64.7 43.1 .16
87.3 68.9 62.7
79.7 60.8 49.7 .30
81.3 61.3 53.4
77.5 56.8 48.6 <.001
86.4 67.7 61.1
ump coronary artery bypass grafting.
gery c December 2013
FIGURE 2. Kaplan-Meier survival curve by body mass index (P<.05). ONCAB, On-pump coronary artery bypass grafting; OPCAB, off-pump coronary
artery bypass grafting; BMI, body mass index.
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version information was collected prior to 2002. When
the post-2002 conversions were examined under an intent-
to-treat framework, the primary study results (Table 3) did
not change significantly. Although it can be assumed in
a study of this size that cardiac and noncardiac mortality
alike occurred in equal proportions across study subpopula-
tions, long-term mortality was all cause and may not reflect
cardiac mortality accurately.
CONCLUSIONS
Patients with BMIs< 25 compared with>35 remain
a high-risk group undergoing CABG. Short-term outcomes
are improved in those patients with a BMI<25 who under-
went coronary artery bypass without the use of the CPB cir-
cuitry. Long-term outcomes are similar among surgical
groups. Further methods should be researched to attenuate
morbidity and mortality for patients at either BMI extremes.
The authors from Emory University express their gratitude to
staff members Kim Baio for project oversight, to Jean Walker
and Susan Joyce for data abstraction, and to Deborah Canup for
database management.
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